The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis-Reference-Cited by-同舟云学术

The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis

Published:2017-07-04 Issue:4 Volume:233 Page:2882-2888
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Bahrami Afsane¹²,Joodi Marjan³⁴,Maftooh Mina⁵,Ferns Gordon A.⁶,M. Ahmadi Mehrdad⁵,Hassanian Seyed M.⁵^ORCID,Avan Amir⁵⁷^ORCID

Affiliation:

1. Department of Modern Sciences and Technologies; Faculty of Medicine; Mashhad University of Medical Sciences; Mashhad Iran

2. Student Research Committee; Faculty of Medicine; Mashhad University of Medical Sciences; Mashhad Iran

3. Department of Pediatric Surgery; Faculty of Medicine; Mashhad University of Medical Sciences; Mashhad Iran

4. Endoscopic and Minimally Invasive Surgery Research Center; Sarvar Children's Hospital; Mashhad Iran

5. Metabolic Syndrome Research Center; Mashhad University of Medical Sciences; Mashhad Iran

6. Division of Medical Education, Falmer, Brighton; Brighton and Sussex Medical School; Sussex UK

7. Cancer Research Center; Mashhad University of Medical Sciences; Mashhad Iran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference51 articles.

1. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility;Astuti;Nature Genetics,2012

2. Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia;Ayatollahi;Journal of Research in Medical Sciences,2017

3. Anaplastic Wilms’ tumour, a subtype displaying poor prognosis, harbours p53 gene mutations;Bardeesy;Nature Genetics,1994

4. Cytogenetic abnormalities and clinical outcome in Wilms tumor: A study by the UK cancer cytogenetics group and the UK Children's Cancer Study Group;Bown;Pediatric Blood & Cancer,2002

5. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor;Breslow;Pediatric Blood & Cancer,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New mutation in WT1 gene in a boy with an incomplete form of Denys-Drash syndrome;Medicine;2021-05-14

2. A rare case of an isolated PAX6 mutation, aniridia, and Wilms tumor;Ophthalmic Genetics;2020-12-10